Publication | Open Access
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
101
Citations
26
References
2021
Year
This study was registered at ClinicalTrials.gov (NCT03899415).
| Year | Citations | |
|---|---|---|
Page 1
Page 1